📋 What This Calculator Does
The 2010 ACR/EULAR RA classification criteria assign points across four domains: joint involvement (0-5 points), serology (0-3 points), acute phase reactants (0-1 point), and symptom duration (0-1 point). A total score of 6 or more out of 10 classifies the patient as having definite RA.
These criteria were designed for classifying patients with early undifferentiated inflammatory arthritis, not for diagnosing established RA. Patients with well-established joint destruction can meet criteria based on erosive pattern even without a score calculation. The criteria replaced the 1987 ACR criteria, which required at least 6 weeks of symptoms, subcutaneous nodules, and radiographic erosions, features that appear late and miss early treatment opportunities.
💡 Pearls and Pitfalls
✓
High-positive serology is the highest-yield domain. High-positive RF or anti-CCP (more than 3 times the upper limit of normal) contributes 3 of the maximum 10 points. A patient with high-positive anti-CCP and any joint synovitis already has 3-4 points before considering acute phase reactants or duration.
✓
Small joint involvement is weighted heavily. Involvement of the MCP, MTP, wrist, or PIP joints (medium and large numbers of small joints) scores higher than large joint involvement alone. This reflects the known predilection of RA for small joints and is the key structural change from the 1987 criteria.
⚠
These are classification criteria, not diagnostic criteria. Meeting a score of 6 or more does not automatically mean the patient has RA in a diagnostic sense. Other conditions, including psoriatic arthritis, early spondyloarthropathy, and reactive arthritis, can produce scores of 6 or more. Clinical judgment and ruling out alternative diagnoses remain essential.
⚠
Seronegative RA can still meet criteria. A patient with negative RF and anti-CCP scores 0 points in the serology domain but can still reach a total score of 6 through joint involvement, elevated acute phase reactants, and symptom duration. Seronegative RA is real and classifiable with these criteria.
🔬 Evidence
The 2010 criteria were developed by a joint ACR/EULAR committee led by Aletaha, Neogi, Silman, and colleagues, and published simultaneously in Arthritis and Rheumatism and Annals of the Rheumatic Diseases in 2010. They were derived from a large international dataset of patients with early inflammatory arthritis and validated against rheumatologist diagnosis as the gold standard. Sensitivity for early RA was substantially higher than the 1987 criteria, enabling earlier treatment and better long-term outcomes.
View References▾
1
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-2581. Original criteria development and validation paper.
2
Neogi T, Aletaha D, Silman AJ, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum. 2010;62(9):2582-2591. Detailed methodology for the scoring system and domain weighting.